Status:
ACTIVE_NOT_RECRUITING
Rehabilitation With an Obturator in Maxillary Defects
Lead Sponsor:
Menoufia University
Collaborating Sponsors:
Mansoura University
Conditions:
Mucormycosis
Eligibility:
All Genders
30-70 years
Brief Summary
During the COVID-19 pandemic, there was a lot of reporting of COVID-19-associated mucormycosis cases. Managing this condition posed a new challenge to clinicians. Management includes therapeutic drugs...
Detailed Description
Globally, the prevalence of mucormycosis varied from 0.005 to 1.7 per million population, while its prevalence is nearly 80 times higher (0.14 per 1000) in India compared to developed countries, in a ...
Eligibility Criteria
Inclusion
- \*Patients who underwent partial, subtotal and hemi-maxillectomy due to COVID-19-associated mucormycosis and who needed the prosthetic rehabilitation with delayed surgical obturator.
Exclusion
- Patients who are unwilling for the study.
- Patients who underwent which bilateral maxillectomies.
- Patients having extensive palatal mucosal loss.
Key Trial Info
Start Date :
February 4 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06515743
Start Date
February 4 2024
End Date
November 30 2024
Last Update
August 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mohammed A. El-Sawy
Al Mansurah, Egypt, 12345